Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Vaccine|January 15, 2013
Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strainsJanny Westdijk, Patrick Koedam, Mario Barro, et al.
Frontiers in Immunology|September 19, 2022
Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccineJake S O'Donnell, Ariel Isaacs, Virginie Jakob, et al.
Vaccine|February 11, 2015
TRANSVAC research infrastructure - Results and lessons learned from the European network of vaccine research and developmentMark J Geels, Regitze L Thøgersen, Carlos A Guzman, et al.
The Journal of Infectious Diseases|November 26, 2013
Targeted nasal vaccination provides antibody-independent protection against Staphylococcus aureusKaren Misstear, Edel A McNeela, Alison G Murphy, et al.
Human Vaccines & Immunotherapeutics|June 10, 2026
Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trialGlenn Hamonic, Supriya Arora, Ravendra Garg, et al.
The Journal of Biological Chemistry|July 29, 2011
Structure and function of a "yellow" protein from saliva of the sand fly Lutzomyia longipalpis that confers protective immunity against Leishmania major infectionXueqing Xu, Fabiano Oliveira, Bianca W Chang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 17, 2012
Lufaxin, a novel factor Xa inhibitor from the salivary gland of the sand fly Lutzomyia longipalpis blocks protease-activated receptor 2 activation and inhibits inflammation and thrombosis in vivoNicolas Collin, Teresa C F Assumpção, Daniella M Mizurini, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2004
Piperidine-containing beta-arylpropionic acids as potent antagonists of alphavbeta3/alphavbeta5 integrinsBart L De Corte, William A Kinney, Li Liu, et al.
Frontiers in Immunology|July 6, 2023
OVX033, a nucleocapsid-based vaccine candidate, provides broad-spectrum protection against SARS-CoV-2 variants in a hamster challenge modelCharlotte Primard, Elodie Monchâtre-Leroy, Judith Del Campo, et al.
NPJ Vaccines|April 7, 2023
Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria modelJulia Ludwig, Stephen W Scally, Giulia Costa, et al.
Pageof 7